announced today its intent to file a New Drug Submission ("NDS") in Canada for MycoVa™, the Company's topical treatment for onychomycosis. On July 18, 2012, Apricus Bio participated in a pre-NDS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results